All Companies
🇬🇧
Juvenescence
PrivateMulti-approach anti-aging therapeutics
Juvenescence is a longevity-focused biotech exploring multiple approaches to combat age-related diseases, including small molecules, gene therapies, and regenerative medicine. The company has subsidiaries working on senolytics, metabolic health, and AI-driven drug discovery for aging.
Founded2017
HQLondon, United Kingdom
CEOGreg Bailey
StatusPrivate
Total Funding$250M
Pipeline
| Drug / Program | Indication | Phase | Technology |
|---|---|---|---|
| Metabolic health program | Metabolic diseases of aging | Phase 1 | Small molecule |
Key People
Greg BaileyCEO & Co-founder